195 related articles for article (PubMed ID: 29681581)
21. Reassessment of Differentiated Thyroid Cancer Patients Using the Eighth TNM/AJCC Classification System: A Comparative Study.
Shteinshnaider M; Muallem Kalmovich L; Koren S; Or K; Cantrell D; Benbassat C
Thyroid; 2018 Feb; 28(2):201-209. PubMed ID: 29256827
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma.
Kim TH; Kim YN; Kim HI; Park SY; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Kim K; Jeong JG; Kim SW; Chung JH
Oral Oncol; 2017 Aug; 71():81-86. PubMed ID: 28688696
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of the prognostic value of the seventh and eighth edition of
Zhong H; Ma R; Gong L; Chen CG; Tang P; Ren P; Jiang HJ; Yu ZT
Zhonghua Wai Ke Za Zhi; 2017 Dec; 55(12):903-908. PubMed ID: 29224264
[No Abstract] [Full Text] [Related]
24. Staging systems for papillary thyroid carcinoma: a study of 2 tertiary referral centers.
Lang BH; Chow SM; Lo CY; Law SC; Lam KY
Ann Surg; 2007 Jul; 246(1):114-21. PubMed ID: 17592299
[TBL] [Abstract][Full Text] [Related]
25. A Comparison of the Seventh and Eighth Editions of the AJCC Staging Systems to Predict Recurrence in Papillary Thyroid Microcarcinoma.
Chen Z; Ruan J; Yao Y; Wen L; Mao Z; Chen S; Zhu H; Zhao Y; Li Z; Fahey TJ; Teng L; Wang W
Ann Surg Oncol; 2021 Oct; 28(11):6564-6571. PubMed ID: 33521903
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of the sixth edition AJCC/UICC TNM classification for differentiated thyroid carcinoma with extrathyroid extension.
Wada N; Nakayama H; Suganuma N; Masudo Y; Rino Y; Masuda M; Imada T
J Clin Endocrinol Metab; 2007 Jan; 92(1):215-8. PubMed ID: 17077130
[TBL] [Abstract][Full Text] [Related]
27. Prognostic importance of sclerosing variant in papillary thyroid carcinoma.
Falvo L; Giacomelli L; D'Andrea V; Marzullo A; Guerriero G; de Antoni E
Am Surg; 2006 May; 72(5):438-44. PubMed ID: 16719201
[TBL] [Abstract][Full Text] [Related]
28. [Prognostically relevant factors in follicular thyroid cancer].
Böttger T; Klupp J; Sorger K; Junginger T
Langenbecks Arch Chir; 1990; 375(5):266-71. PubMed ID: 2259260
[TBL] [Abstract][Full Text] [Related]
29. Recommendation for subclass evaluation of TNM stage iva papillary thyroid carcinomas: T4aN1b patients are at risk for recurrence and survival.
Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
Ann Surg Oncol; 2008 May; 15(5):1511-7. PubMed ID: 18299932
[TBL] [Abstract][Full Text] [Related]
30. An Analysis of The American Joint Committee on Cancer 8th Edition T Staging System for Papillary Thyroid Carcinoma.
Tran B; Roshan D; Abraham E; Wang L; Garibotto N; Wykes J; Campbell P; Ebrahimi A
J Clin Endocrinol Metab; 2018 Jun; 103(6):2199-2206. PubMed ID: 29672723
[TBL] [Abstract][Full Text] [Related]
31. Modification of the Tumor-Node-Metastasis Staging System for Differentiated Thyroid Carcinoma by Considering Extra-Thyroidal Extension and Lateral Cervical Lymph Node Metastasis.
Kim M; Kim WG; Jeon MJ; Kim HK; Yi HS; Kim ES; Kim BH; Kim WB; Shong YK; Kang HC; Kim TY
Endocrinol Metab (Seoul); 2020 Mar; 35(1):149-156. PubMed ID: 32207275
[TBL] [Abstract][Full Text] [Related]
32. The presence of large lymph node metastasis as a prognostic factor of papillary thyroid carcinoma.
Kitajiri S; Hiraumi H; Hirose T; Hosaka N
Auris Nasus Larynx; 2003 May; 30(2):169-74. PubMed ID: 12753989
[TBL] [Abstract][Full Text] [Related]
33. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
34. Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer.
He XD; Li JJ; Liu W; Qu Q; Hong T; Xu XQ; Li BL; Wang Y; Zhao HT
World J Gastroenterol; 2015 Apr; 21(15):4620-6. PubMed ID: 25914471
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic characteristics and prognosis of diffuse sclerosing variant of papillary thyroid carcinoma in Japan: an 18-year experience at a single institution.
Fukushima M; Ito Y; Hirokawa M; Akasu H; Shimizu K; Miyauchi A
World J Surg; 2009 May; 33(5):958-62. PubMed ID: 19198928
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Value of Extranodal Tumor Extension in Papillary Thyroid Carcinoma: Proposal for Upstaging of Cases with Extranodal Tumor Extension.
Ito Y; Miyauchi A; Masuoka H; Higashiyama T; Kihara M; Miya A
World J Surg; 2020 Feb; 44(2):638-643. PubMed ID: 31605175
[TBL] [Abstract][Full Text] [Related]
37. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
[TBL] [Abstract][Full Text] [Related]
39. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
40. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
